William Abraham

Dr. William T. Abraham is Professor of Internal Medicine, Physiology and Cell Biology and College of Medicine Distinguished Professor at The Ohio State University. He earned his medical degree from Harvard Medical School and completed his post-graduate training at the University of Colorado. At The Ohio State University, Dr. Abraham developed one of the largest and most successful academic programs of Cardiovascular Medicine in the U.S. He is board certified in Internal Medicine and Advanced Heart Failure and Transplant Cardiology. He has been recognized as one of the “Best Doctors in America” for twenty consecutive years and is ranked among the top 10% of physicians nationally for patient satisfaction. He has made major contributions to advancing basic and clinical science in heart failure and has frequently served as national or international principal investigator for Phase 1 through Phase 3 clinical trials, leading to the approval of several new therapies for heart failure, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, non-invasive and implantable hemodynamic monitoring systems, transvenous phrenic nerve stimulation, cardiac contractility modulation, transcatheter mitral valve repair, and baroreflex activation therapy. Dr. Abraham has authored more than 1,500 original papers, abstracts, book chapters, and review articles; many published in high impact journals. He has been named to the Clarivate Analytics Highly Cited Researchers list and as one of The World’s Most Influential Scientific Minds. In 2017, he received the Distinguished Scientist Award from the American College of Cardiology, in recognition of his contributions to advancing cardiovascular medicine. In 2022, Dr. Abraham received the Pioneer Award from the Heart Failure Society of America, given to an innovator in the field of heart failure.